Northern Trust Corp Beam Therapeutics Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 740,506 shares of BEAM stock, worth $19.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
740,506
Previous 691,091 7.15%
Holding current value
$19.5 Million
Previous $16.9 Million 8.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$21.55 - $30.35 $1.06 Million - $1.5 Million
49,415 Added 7.15%
740,506 $18.4 Million
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $760,812 - $1.12 Million
33,709 Added 5.13%
691,091 $16.9 Million
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $38,153 - $58,722
-1,798 Reduced 0.27%
657,382 $15.4 Million
Q1 2024

May 14, 2024
SELL
$23.46 - $45.07 $219,632 - $421,945
-9,362 Reduced 1.4%
659,180 $21.8 Million
Q4 2023

Feb 13, 2024
BUY
$17.69 - $30.76 $246,492 - $428,609
13,934 Added 2.13%
668,542 $18.2 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $682,154 - $962,309
29,646 Added 4.74%
654,608 $15.7 Million
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $498,381 - $611,758
16,998 Added 2.8%
624,962 $20 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $147,312 - $238,387
-4,886 Reduced 0.8%
607,964 $18.6 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $308,899 - $433,956
8,410 Added 1.39%
612,850 $24 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $1.68 Million - $2.98 Million
42,337 Added 7.53%
604,440 $28.8 Million
Q2 2022

Aug 12, 2022
BUY
$29.86 - $62.36 $3.02 Million - $6.3 Million
101,060 Added 21.92%
562,103 $21.8 Million
Q1 2022

May 13, 2022
SELL
$53.73 - $82.16 $1.02 Million - $1.55 Million
-18,915 Reduced 3.94%
461,043 $26.4 Million
Q4 2021

Feb 08, 2022
BUY
$68.02 - $99.06 $72,169 - $105,102
1,061 Added 0.22%
479,958 $38.2 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $2.14 Million - $3.38 Million
25,323 Added 5.58%
478,897 $41.7 Million
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $3.26 Million - $6.54 Million
50,817 Added 12.62%
453,574 $58.4 Million
Q1 2021

May 12, 2021
SELL
$71.28 - $120.75 $1.74 Million - $2.95 Million
-24,400 Reduced 5.71%
402,757 $32.2 Million
Q4 2020

Feb 11, 2021
BUY
$22.24 - $95.63 $1 Million - $4.31 Million
45,101 Added 11.8%
427,157 $34.9 Million
Q3 2020

Nov 16, 2020
BUY
$19.0 - $30.57 $4.08 Million - $6.57 Million
214,813 Added 128.44%
382,056 $9.41 Million
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $552,671 - $1.04 Million
36,217 Added 27.64%
167,243 $4.68 Million
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $1.74 Million - $3.83 Million
131,026 New
131,026 $2.36 Million

Others Institutions Holding BEAM

# of Institutions
253
Shares Held
78.6M
Call Options Held
304K
Put Options Held
142K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.85B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email